Eur Respir J 1997; 10: 2794-2800
Copyright © ERS Journals Ltd 1997
Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
R Antonelli Incalzi,
L Fuso,
M De Rosa,
F Forastiere,
E Rapiti,
B Nardecchia,
and
R Pistelli
The aim of this study was to assess the prognostic role of co-morbidity in severe chronic obstructive pulmonary disease (COPD). A cohort of 270 COPD patients, mean (+/-SD) age 67+/-9 yrs, consecutively discharged from a University Hospital after an acute exacerbation was studied. Mean (+/-SD) forced expiratory volume in one second (FEV1) was 34+/-16% of predicted and FEV1/forced vital capacity (FVC) was 40.5+/-13.8%. The most common co-morbid diseases were: hypertension (28%), diabetes mellitus (14%), and ischaemic heart disease (10%). Clinical, electrocardiogram (ECG), and respiratory function data taken at the time of discharge were collected from the clinical records. The Charlson's index was used to quantify co-morbidity. Follow-up was conducted by means of telephone calls. Multivariate survival analysis was used to identify the independent predictors of death. The median survival of the cohort was 3.1 yrs. Death was predicted by the following variables: age (hazard rate (HR) 1.04; 95% confidence intervals (95% CI) 1.02-1.05), ECG signs of right ventricular hypertrophy (HR 1.76; 95% CI 1.30-2.38), chronic renal failure (HR 1.79; 95% CI 1.05-3.02), ECG signs of myocardial infarction or ischaemia (HR 1.42; 95% CI 1.02-1.96), FEV1 < 590 mL (HR 1.49; 95% CI 0.97-2.27). A score based upon these variables predicted mortality at 5 yrs with a sensitivity of 63% and a specificity of 77%. Selected co-morbid diseases and electrocardiogram signs of right ventricular hypertrophy play a major prognostic role in advanced chronic obstructive pulmonary disease. The clinical assessment of patients with chronic obstructive pulmonary disease should include these important and easily measurable variables.
This article has been cited by other articles:

|
 |

|
 |
 
J. P. de Torres, C. G. Cote, M. V. Lopez, C. Casanova, O. Diaz, J. M. Marin, V. Pinto-Plata, M. M. de Oca, H. Nekach, L. J. Dordelly, et al.
Sex differences in mortality in patients with COPD
Eur. Respir. J.,
March 1, 2009;
33(3):
528 - 535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Luppi, F. Franco, B. Beghe, and L. M. Fabbri
Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities
Proceedings of the ATS,
December 1, 2008;
5(8):
848 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Mannino, D. Thorn, A. Swensen, and F. Holguin
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Eur. Respir. J.,
October 1, 2008;
32(4):
962 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Faustini, C. Marino, D. D'Ippoliti, F. Forastiere, V. Belleudi, and C. A. Perucci
The impact on risk-factor analysis of different mortality outcomes in COPD patients
Eur. Respir. J.,
September 1, 2008;
32(3):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Moro, C. Pedone, S. Scarlata, V. Malafarina, F. Fimognari, and R. Antonelli-Incalzi
Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
Angiology,
July 1, 2008;
59(3):
357 - 364.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz
Cardiac Disease in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
543 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Mueller, M. Tamm, and C. Mueller
Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD
Chest,
May 1, 2008;
133(5):
1088 - 1094.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M T Dransfield, S M Rowe, J E Johnson, W C Bailey, and L B Gerald
Use of {beta} blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
Thorax,
April 1, 2008;
63(4):
301 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Stafoggia, F Forastiere, D Agostini, N Caranci, F de'Donato, M Demaria, P Michelozzi, R Miglio, M Rognoni, A Russo, et al.
Factors affecting in-hospital heat-related mortality: a multi-city case-crossover analysis
J Epidemiol Community Health,
March 1, 2008;
62(3):
209 - 215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lederer, E. K. T. Benn, R. G. Barr, J. S. Wilt, G. Reilly, J. R. Sonett, S. M. Arcasoy, and S. M. Kawut
Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
February 15, 2008;
177(4):
450 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hernandez and J. Roca
COPD exacerbations: who is safe to be managed at home
Chronic Respiratory Disease,
November 1, 2007;
4(4):
187 - 188.
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tkac, S. F. P. Man, and D. D. Sin
Review: Systemic consequences of COPD
Therapeutic Advances in Respiratory Disease,
October 1, 2007;
1(1):
47 - 59.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anzueto, S. Sethi, and F. J. Martinez
Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
554 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A Seamark, C. J Seamark, and D. M G Halpin
Palliative care in chronic obstructive pulmonary disease: a review for clinicians
J R Soc Med,
May 1, 2007;
100(5):
225 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cote, M. D. Zilberberg, S. H. Mody, L. J. Dordelly, and B. Celli
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Eur. Respir. J.,
May 1, 2007;
29(5):
923 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Stolz, M. Christ-Crain, N. G. Morgenthaler, J. Leuppi, D. Miedinger, R. Bingisser, C. Muller, J. Struck, B. Muller, and M. Tamm
Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD
Chest,
April 1, 2007;
131(4):
1058 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung
Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan
Chest,
March 1, 2007;
131(3):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
British Thoracic Society Guideline Development Gro
Intermediate care--Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline
Thorax,
March 1, 2007;
62(3):
200 - 210.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Sin, E. Wong, I. Mayers, D. C. Lien, D. Feeny, H. Cheung, W. Q. Gan, and S. F. P. Man
Effects of Nocturnal Noninvasive Mechanical Ventilation on Heart Rate Variability of Patients With Advanced COPD
Chest,
January 1, 2007;
131(1):
156 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Sin, N. R. Anthonisen, J. B. Soriano, and A. G. Agusti
Mortality in COPD: role of comorbidities
Eur. Respir. J.,
December 1, 2006;
28(6):
1245 - 1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Stenfors
Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Ostersund, Sweden: Patient Characteristics and Estimated Prevalence.
Chest,
September 1, 2006;
130(3):
666 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marti, X. Munoz, J. Rios, F. Morell, and J. Ferrer
Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy.
Eur. Respir. J.,
April 1, 2006;
27(4):
689 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E H Baker, C H Janaway, B J Philips, A L Brennan, D L Baines, D M Wood, and P W Jones
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Thorax,
April 1, 2006;
61(4):
284 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Poster presentations
Thorax,
December 1, 2005;
60(suppl_2):
ii53 - ii120.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Soler-Cataluna, M A Martinez-Garcia, P Roman Sanchez, E Salcedo, M Navarro, and R Ochando
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Thorax,
November 1, 2005;
60(11):
925 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Holguin, E. Folch, S. C. Redd, and D. M. Mannino
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
Chest,
October 1, 2005;
128(4):
2005 - 2011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Huiart, P. Ernst, and S. Suissa
Cardiovascular Morbidity and Mortality in COPD
Chest,
October 1, 2005;
128(4):
2640 - 2646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ai-Ping, K.-H. Lee, and T.-K. Lim
In-Hospital and 5-Year Mortality of Patients Treated in the ICU for Acute Exacerbation of COPD: A Retrospective Study
Chest,
August 1, 2005;
128(2):
518 - 524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Miyazaki, N Kikuchi, H Satoh, K Sekizawa, M L G Janssen-Heijnen, and J W W Coebergh
Comorbidity in elderly NSCLC patients
Thorax,
August 1, 2005;
60(8):
704 - 704.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. C. Nizet, F. J. J. van den Elshout, Y. F. Heijdra, M. J. T. van de Ven, P. G. H. Mulder, and H. Th. M. Folgering
Survival of Chronic Hypercapnic COPD Patients Is Predicted by Smoking Habits, Comorbidity, and Hypoxemia
Chest,
June 1, 2005;
127(6):
1904 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Hersh, D. L. DeMeo, E. Al-Ansari, V. J. Carey, J. J. Reilly, L. C. Ginns, and E. K. Silverman
Predictors of Survival in Severe, Early Onset COPD
Chest,
November 1, 2004;
126(5):
1443 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kjoller, L. Kober, K. Iversen, C. Torp-Pedersen, and Trace Study Group
Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction
Eur J Heart Fail,
January 1, 2004;
6(1):
71 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. Groenewegen, A. M.W.J. Schols, and E. F.M. Wouters
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Chest,
August 1, 2003;
124(2):
459 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pistelli, P. Lange, and D.L. Miller
Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity
Eur. Respir. J.,
May 1, 2003;
21(40_suppl):
10S - 14s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oga, K. Nishimura, M. Tsukino, S. Sato, and T. Hajiro
Analysis of the Factors Related to Mortality in Chronic Obstructive Pulmonary Disease: Role of Exercise Capacity and Health Status
Am. J. Respir. Crit. Care Med.,
February 15, 2003;
167(4):
544 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Domingo-Salvany, R. Lamarca, M. Ferrer, J. Garcia-Aymerich, J. Alonso, M. Felez, A. Khalaf, R. M. Marrades, E. Monso, J. Serra-Batlles, et al.
Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
September 1, 2002;
166(5):
680 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Fan, J. R. Curtis, S.-P. Tu, M. B. McDonell, and S. D. Fihn
Using Quality of Life to Predict Hospitalization and Mortality in Patients With Obstructive Lung Diseases*
Chest,
August 1, 2002;
122(2):
429 - 436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Eur. Respir. J.,
July 1, 2002;
20(36_suppl):
9S - 19s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Almagro, E. Calbo, A. Ochoa de Echaguen, B. Barreiro, S. Quintana, J. L. Heredia, and J. Garau
Mortality After Hospitalization for COPD*
Chest,
May 1, 2002;
121(5):
1441 - 1448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, P. Noschese, G. D'Amato, and M. G. Matera
The Pharmacologic Treatment of Uncomplicated Arterial Hypertension in Patients With Airway Dysfunction
Chest,
January 1, 2002;
121(1):
230 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Nevins and S. K. Epstein
Predictors of Outcome for Patients With COPD Requiring Invasive Mechanical Ventilation
Chest,
June 1, 2001;
119(6):
1840 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles, C. Murio, and T. Guerrero
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
Eur. Respir. J.,
May 1, 2001;
17(5):
928 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.M. Anto, P. Vermeire, J. Vestbo, and J. Sunyer
Epidemiology of chronic obstructive pulmonary disease
Eur. Respir. J.,
May 1, 2001;
17(5):
982 - 994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moretti, C. Cilione, A. Tampieri, C. Fracchia, A. Marchioni, and S. Nava
Incidence and causes of non-invasive mechanical ventilation failure after initial success
Thorax,
October 1, 2000;
55(10):
819 - 825.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. F Guite, R. Dundas, and P. G J Burney
Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma
Thorax,
April 1, 1999;
54(4):
301 - 307.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the European Respiratory Society.
|